Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
Haoyu Zhang(National Institutes of Health), Jose E. Castelao(Servicio Gallego de Salud), Volker Arndt(German Cancer Research Center), Zumuruda Abu Ful(Carmel Medical Center), Mariarosaria Calvello(European Institute of Oncology), Hiltrud Brauch(German Cancer Research Center), Natalia Bogdanova(Medizinische Hochschule Hannover), Banu Arun(The University of Texas Health Science Center at Houston), Thomas Brüning(Institute for Prevention and Occupational Medicine), Ana Blanco(Fundación Pública Galega de Medicina Xenómica), Xia Jiang(Xuzhou Medical College), Trinidad Caldés(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Ni Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Sara Y. Brucker(University Children's Hospital Tübingen), Heiko Becher(Universität Hamburg), Davide Bondavalli(European Institute of Oncology), Annegien Broeks, Joe Dennis(University of Cambridge), Jacopo Azzollini(Fondazione IRCCS Istituto Nazionale dei Tumori), Julie Lecarpentier(Inserm), Alison M. Dunning(University of Cambridge), Daniel Barrowdale(University of Cambridge), Matthias W. Beckmann(Universitätsklinikum Erlangen), Thomas U. Ahearn(Harvard University), Irene L. Andrulis(University of Toronto), Katarzyna Białkowska(International Hereditary Cancer Center), Sabine Behrens(German Cancer Research Center), Javier Benı́tez(Spanish National Cancer Research Centre), Daniel R. Barnes(University of Cambridge), Paul L. Auer(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Carl Blomqvist(University of Helsinki), Helen Byers(Manchester Academic Health Science Centre), Daniele Campa(University of Pisa), Ignacio Briceño(Universidad de La Sabana), Stig E. Bojesen(University of Copenhagen), Saundra S. Buys(University of Utah), Tracy A. O’Mara(QIMR Berghofer Medical Research Institute), Hermann Brenner(Universidad de Granada), Hoda Anton‐Culver(University of California, Irvine), Guanghao Qi(Johns Hopkins University), Bernardo Bonanni(European Institute of Oncology), Kristan J. Aronson(Queen's University), Qin Wang(University of Cambridge), Barbara Burwinkel(German Cancer Research Center), Kristiina Aittomäki(University of Helsinki), Åke Borg(Lund University), Manjeet K. Bolla(University of Cambridge), Maria A. Caligo(Azienda Ospedaliera Universitaria Pisana), Jonathan Beesley(QIMR Berghofer Medical Research Institute), Marina Bermisheva(Russian Academy of Sciences)
Cited by 580
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.1k
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k